SCHEMBL8946989

SCHEMBL8946989

Nc1cc2c(O)c(/N=N/c3ccc(/N=N/c4ccc(S(=O)(=O)O)cc4)c4ccc(S(=O)(=O)O)cc34)c(S(=O)(=O)O)cc2cc1S(=O)(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD40 P25942 1/20 0.57
CD40LG P29965 1/20 0.57
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
HSD17B10 Q99714 1/20 0.56
ENPP2 Q13822 7/20 0.56
MEN1 O00255 1/20 0.54
THRB P10828 1/20 0.54
KMT2A Q03164 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
SENP2 Q9HC62 4/20 0.53
SENP3 Q9H4L4 3/20 0.53
SENP1 Q9P0U3 3/20 0.53
SUMO2 P61956 3/20 0.53
SUMO1 P63165 3/20 0.53
SENP7 Q9BQF6 3/20 0.53
PHLPP2 Q6ZVD8 1/20 0.53
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
ALDH1A1 P00352 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29635262 1.00 CD40 (0.57) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL9332175 1.00 CD40 (0.57) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL9332169 1.00 CD40 (0.57) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL5177418 1.00 CD40 (0.57) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL28389935 0.99 CD40 (0.56) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL15127525 0.94 ALDH1A1 (0.55) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL14327569 0.94 CYP2C9 (0.53) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL13629269 0.94 CYP2C9 (0.55) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL9335047 0.93 MEN1 (0.58) CD40CD40LGCYP2C9CYP2C19HSD17B10
SCHEMBL9335040 0.93 MEN1 (0.58) CD40CD40LGCYP2C9CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230383-B1 DETAILING AGENT FOR THREE-DIMENSIONAL (3D) PRINTING HEWLETT PACKARD DEVELOPMENT CO (US) 2024-02-28 EP claimed
EP-3230383-A1 DETAILING AGENT FOR THREE-DIMENSIONAL (3D) PRINTING Hewlett-Packard Development Company, L.P. (US) 2017-10-18 EP claimed
WO-2016171724-A1 DETAILING AGENT FOR THREE-DIMENSIONAL (3D) PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2016-10-27 WO claimed
US-5334435-A Heat resistant, storage stable disazo dyes for high speed, high density recording on plain paper EASTMAN KODAK COMPANY (US) 1994-08-02 US claimed
WO-2024091247-A1 BUILD MATERIAL COMPOSITION AND THERMALLY CONDUCTIVE AGENT FOR THREE-DIMENSIONAL PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2024-05-02 WO disclosed
WO-2024072415-A1 THREE-DIMENSIONAL PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2024-04-04 WO disclosed
EP-3230383-B1 DETAILING AGENT FOR THREE-DIMENSIONAL (3D) PRINTING HEWLETT PACKARD DEVELOPMENT CO (US) 2024-02-28 EP disclosed
US-20240025113-A1 THREE-DIMENSIONAL PRINTING PERIDOT PRINT LLC 2024-01-25 US disclosed
US-20230398733-A1 THREE-DIMENSIONAL PRINTING PERIDOT PRINT LLC 2023-12-14 US disclosed
US-11780988-B2 Three-dimensional printing HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2023-10-10 US disclosed
US-11745417-B2 Three-dimensional printing HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2023-09-05 US disclosed
US-20230234284-A1 THREE-DIMENSIONAL PRINTING HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2023-07-27 US disclosed
US-8758451-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2014-06-24 US disclosed
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-01-16 US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 US disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 US disclosed
US-5334435-A Heat resistant, storage stable disazo dyes for high speed, high density recording on plain paper EASTMAN KODAK COMPANY (US) 1994-08-02 US disclosed
EP-0348050-A1 Colorant for printing IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CD40 4884/4885CD40LG 4880/4885CYP2C9 1172/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CD40 4884/4885CD40LG 4880/4885CYP2C9 1172/4885
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 CD40 4884/4885CD40LG 4880/4885CYP2C9 1172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.